Welcome to our dedicated page for Kenvue SEC filings (Ticker: KVUE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Kenvue Inc. filings document the public-company disclosures of a pure-play consumer health issuer with brands including Tylenol, Listerine, Johnson’s, Aveeno, Neutrogena and BAND-AID Brand. Its SEC record includes material-event reports, proxy and governance disclosures, shareholder voting matters, capital-structure information, operating and financial results, and consumer-health regulatory topics.
The company’s filings also cover executive officer appointments and compensatory arrangements, material definitive agreements, risk-factor disclosures and common-stock matters. Proxy materials and Form 8-K reports provide formal records of board governance, security-holder votes and other events affecting Kenvue’s corporate structure and reporting obligations.
Kenvue Inc. director Betsy D. Holden received a grant of 10,309 Deferred Share Units at $17.46 per unit under the company’s Amended and Restated Deferred Fee Plan for Directors. Each DSU converts into one share of common stock when her board service ends, bringing her total DSU holdings to 36,626.662 units, including units credited as dividend equivalents. This is a compensation-related equity award rather than an open-market stock purchase or sale.
Kenvue Inc. director Larry J. Merlo received a grant of 16,036 Deferred Share Units (DSUs). The DSUs were awarded at a reference price of $17.46 per unit and are structured to convert into an equal number of Kenvue common shares when his board service ends. After this award, Merlo holds a total of 56,975.45 DSUs, which includes units previously credited as dividend equivalents under the company’s Amended and Restated Deferred Fee Plan for Directors.
PRABHU VASANT M reported acquisition or exercise transactions in this Form 4 filing.
Kenvue Inc. director Vasant M. Prabhu received a grant of 10,309 Deferred Share Units at $17.46 per unit under the company’s Amended and Restated Deferred Fee Plan for Directors. Each DSU represents one share of common stock, settling when his board service ends, bringing his total DSUs to 36,626.664, including amounts from dividend equivalents.
Sneed Michael E reported acquisition or exercise transactions in this Form 4 filing.
Kenvue Inc. director Michael E. Sneed received a grant of 10,309 Deferred Share Units at a reference price of $17.4600 per unit. Each DSU represents the right to receive one share of common stock, to be settled when his directorship ends. Following this award, he holds 36,626.663 DSUs, including units accumulated as dividend equivalents.
Kenvue Inc. Group President LATAM Leonardo Curado Gomes de Lemos reported routine equity compensation activity involving restricted stock units and common stock. He exercised RSUs corresponding to 24,247.71 shares of common stock, with no open-market purchase or sale.
Of the vested shares, 7,141 were withheld to pay taxes, as noted in the footnotes, leaving him with 17,106.71 common shares held directly after the transactions. His derivative holdings now include 48,491.41 restricted stock units, which each correspond 1-for-1 with Kenvue common stock and vest in three equal installments on 05/01/2026, 05/01/2027, and 05/01/2028, subject to continued service.
Kenvue Inc. director Melanie Healey reported a compensation-related grant of 10,309 Deferred Share Units (DSUs) tied to Kenvue common stock at a reference price of $17.46 per unit. Each DSU represents the right to receive one share of common stock, generally settled after her directorship ends.
Following this award, Healey directly holds 36,626.663 DSUs. The filing notes that this balance includes DSUs acquired as dividend equivalents, meaning additional units credited in lieu of cash dividends rather than open-market purchases.
PAWLUS KATHLEEN M reported acquisition or exercise transactions in this Form 4 filing.
Kenvue Inc. director Kathleen M. Pawlus received a grant of 10,309 Deferred Share Units (DSUs) on May 21, 2026 as part of director compensation. Each DSU represents one share of common stock to be delivered after her board service ends. Following this award, she holds a total of 25,037.675 DSUs directly, including units accumulated from dividend equivalents.
Kenvue Inc. director Richard E. Allison Jr. received a grant of 10,309 Deferred Share Units (DSUs) valued at $17.46 per unit. These DSUs are part of the company's Amended and Restated Deferred Fee Plan for Directors.
Each DSU represents the right to receive one share of Kenvue common stock, to be settled when his board service ends. Following this grant, Allison holds a total of 47,943.229 DSUs directly, including units previously acquired as dividend equivalents. This is a routine, compensation-related equity award, not an open-market purchase or sale.
Mann Erica L reported acquisition or exercise transactions in this Form 4 filing.
Director Erica L. Mann received a grant of 10,309 Deferred Share Units (DSUs) of Kenvue Inc. at a reference price of $17.46 per unit as director compensation. Each DSU represents the right to receive one share of common stock, generally after her board service ends.
Following this award, her directly held DSU balance reported in this filing increased to 19,986.12 DSUs. The footnotes explain that these DSUs are issued under Kenvue’s Amended and Restated Deferred Fee Plan for Directors and that the balance includes DSUs accumulated as dividend equivalents, which mirror dividends paid on the common stock.
Godbole Seemantini reported acquisition or exercise transactions in this Form 4 filing.
Kenvue Inc. director Seemantini Godbole received a grant of 10,309 Deferred Share Units (DSUs) on Kenvue common stock, treated as a compensation award rather than an open-market purchase. Each DSU represents the right to receive one share of common stock upon termination of her directorship.
After this grant and related dividend-equivalent DSUs, her directly held DSU balance increased to 36,626.661 units. These DSUs carry a stated value of $17.46 per unit for this award, but they will be settled in actual Kenvue shares at a future settlement date.